Burkholderia pseudomallei is a serum-resistant Gram-negative bacterium capable of causing disseminated infections with metastatic complications. However, its interaction with nonphagocytic cells is poorly understood. We observed that exposure of B. pseudomallei and the closely related yet avirulent B. thailandensis to human plasma increased epithelial cell invasion by >20 fold. Enhanced invasion was primarily driven by a plasma factor, which required a functional complement cascade, but surprisingly, was downstream of C3 mediated opsonisation.
dissemination of the bacterium from the primary focus of infection to peripheral organs such as the liver (Hoppe et al., 1999) . There are two mechanisms that can be employed by invasive bacteria to trigger uptake by host nonphagocytic cells-the trigger and the zipper mechanism. The "trigger" model involves active secretion of bacterial effectors into the host cytoplasm, via a dedicated secretion apparatus such as a Type III secretion system (T3SS). These effectors then regulate actin skeleton dynamics, leading to the formation of a macropinocytic pocket, which engulfs the bacterium (Cossart & Sansonetti, 2004) . The "zipper" model involves bacteria binding to cell surface receptors, either directly via bacterial adhesins, or by recruiting extracellular matrix proteins, which then bind to the surface receptors.
Engaging these surface receptors results in a signaling cascade, which directs cytoskeletal rearrangements and membrane extensions. This leads to the formation of a vacuole engulfing the bacterium via a zippering process (Cossart & Sansonetti, 2004) . Plasma proteins that act as adaptors to bind cell surface receptors include vitronectin, fibronectin, and fibrinogen (Pizarro-Cerda & Cossart, 2006) . The mechanisms mediating B. pseudomallei invasion of nonphagocytic cells are largely unknown.
B. pseudomallei and B. thailandensis are highly resistant to the bactericidal activity of human serum (Ismail, Razak, Mohamed, Embi, & Omar, 1988; Woodman, Worth, & Mark Wooten, 2012) . A Type II O-polysaccharide moiety produced as part of the Burkholderia lipopolysaccharide (LPS) is required for complete serum resistance, and is critical for bacterial virulence in various animal models of infection (DeShazer, Brett, & Woods, 1998) . Current evidence suggests that this LPS layer confers serum resistance by dampening the microbicidal potency of the membrane attack complex, but does not interfere with complement deposition and membrane attack complex assembly on the bacterial surface (Egan & Gordon, 1996; Woodman et al., 2012) .
Many pathogens recruit plasma proteins and extracellular matrix (ECM) proteins to interfere with complement deposition and immune recognition, and to mediate host cell adhesion, invasion, and translocation (Dinkla et al., 2003; Lambris, Ricklin, & Geisbrecht, 2008; Ljungh, Moran, & Wadstrom, 1996) . In this study, we examined the effect of bacterial exposure to human plasma on the invasion of nonphagocytic cells. Our findings show human plasma dramatically enhances the ability of Burkholderia, and to a lesser extent, nonhypermucoviscous Klebsiella pneumoniae, to invade various nonphagocytic cell types. This enhanced invasion requires both a functional complement cascade and vitronectin, and could be suppressed by integrin inhibitors.
| RESULTS

| Enhanced invasion of Burkholderia into nonphagocytic cells upon plasma exposure
In agreement with previous studies (DeShazer et al., 1998; Woodman et al., 2012) , we observed that both B. pseudomallei and B. thailandensis are highly serum resistant, capable of actively growing in 50% human plasma ( Figure 1a) . Exposure of B. pseudomallei to plasma for 1 hr prior to infection of A549 epithelial cells led to a > 20 fold increase in intracellular bacterial counts at 2 hr postinfection (Figure 1b) . A similar effect was observed with B. pseudomallei in HEK293T and MDA-MB-231 epithelial cells and B. thailandensis in A549 cells (fold increases of 11, 48, and 1,000 respectively, Figure S1a -c). Plasma exposure of B. thailandensis also greatly increased its ability to invade HepG2 cells, with an increase of 10,000 fold compared to Luria Bertani (LB) or heat-treated (HT) plasma exposure, as measured at 3 hr postinfection (Figure 1c ). This increased cell invasion translated into greater intracellular bacterial counts at a 6 hr postinfection time point for both species (Figure 1d,e) . Both B. pseudomallei and B. thailandensis are capable of inducing host-cell fusion during the latter stages of infection, resulting in the formation of multinucleated giant cells (MNGC). Widespread MNGC and plaque formation was observed in epithelial cells infected with plasma exposed B. pseudomallei (Figure 1f) . B. pseudomallei exposed to heat-treated plasma formed less MNGC, and did not display any plaque formation (Figure 1f) . Similarly during B. thailandensis infection, more widespread MNGC formation was observed when the bacteria were exposed to plasma before infection (Figures 1g,h ). Therefore, plasma exposure potently enhances the ability of Burkholderia to invade a variety of nonphagocytic cells, resulting in widespread cell fusion and bacterial spreading at later time points postinfection.
| Enhanced invasion requires a complementdependent plasma factor
The T3SS of some intracellular pathogens can mediate epithelial cell invasion. We observed that a B. pseudomallei ΔbsaN mutant, which is defective in a key regulatory protein required for expression of the T3SS3 cluster (Chen et al., 2014) , could invade just as well as the wildtype bacteria (Figure 2a) . B. pseudomallei ΔbsaN is also defective in Type VI secretion system (T6SS) expression, as it is needed for expression of VirAG and BprC, which are required for T6SS induction (Chen et al., 2011) . In order to explore whether plasma exposure leads to a transcriptional up-regulation of other virulence genes, which could in turn mediate epithelial cell entry, we utilized the bacterial RNA polymerase targeting antibiotic rifampicin. B. pseudomallei strain KHW had a minimum inhibitory concentration (MIC) of 64 μg/ml for rifampicin. A subinhibitory dose of 32 μg/ml was able to completely suppress up-regulation of the hcp gene upon cysteine exposure in B.
pseudomallei, indicating the efficacy of rifampicin in supressing de novo transcription at this concentration (Figure 2b ). However, rifampicin treatment had no effect on the invasion of A549 cells by B.
pseudomallei upon plasma exposure (Figure 2c ). These results suggest that increased invasion is unlikely to be due to the up-regulation of bacterial virulence genes in response to a plasma-factor. However, this does not rule out a role for bacteria in this invasion, because the rifampicin concentration used was titrated to inhibit new transcription, but is not bactericidal. We observed that UV inactivation of B. thailandensis followed by plasma exposure dramatically reduced the number of bacilli associated with HepG2 cells after 1.5 hr of infection, compared to live bacteria exposed to plasma ( Figure S2 ). Therefore, while a plasma factor confers a greatly enhanced invasive phenotype to the bacteria, live bacteria is required for successful association with epithelial cells.
As we had previously observed that heat-treatment of plasma for 30 min at 56°C completely abolished its ability to enhance bacterial (h) a fusion index was used to quantify the total percentage of nuclei within MNGC in (g). Each column in the bar chart is the average of eight measurements per experiment. Data from n = 2 or n = 3 experiments are shown in a scatter plot with mean AE SD in (a-e). Tables below graphs in (be) denote fold changes relative to Luria Bertani (LB), with each column representing a set of experiments. Circles represent experiment 1, triangles experiment 2, and squares experiment 3. * denotes P < 0.05 FIGURE 2 Plasma-enhanced invasion of Burkholderia is dependent on a plasma derived factor. (a) Bp ΔbsaN and Bp were treated with HT plasma Ht (pl) and pl prior to infection of A549 cells, and intracellular bacterial counts were determined at 2 hr post-infection. (b) B. pseudomallei (Bp) was treated with 32 μg/mL rifampicin and hcp expression was measured using real-time polymerase chain reaction. Each column in the bar chart is the average of eight measurements per experiment. (c) Bp treated with 32 μg/mL rifampicin was exposed to pl prior to infection of A549 cells, and intracellular bacterial counts were subsequently determined. (d) Bp was treated with pl and 10 mM EDTA (pl + EDTA) before infection of A549 cells and determination of intracellular bacteria counts. (e,f) Bp was treated with C3 and C5 depleted human serum, before infection of A549 cells. Addition of C3 and C5 protein to the C3 and C5 depleted serum respectively restore the invasion phenotype. Data from n = 2 or n = 3 experiments are shown in a scatter plot with mean AE SD in (a, c-f). Tables below graphs in (a, c-f) denote fold changes relative to LB, with each column representing a set of experiments. Circles represent experiment 1, triangles experiment 2, and squares experiment 3. * denotes P < 0.05 invasion (Figure 1b,c) , we next explored a possible involvement of the complement cascade. Complement components are well known to be heat-labile, and require divalent cations for activation (Law, Kenneth, & Reid, 1995) . Adding 10 mM EDTA, a chelating agent to plasma reduced its ability to enhance Burkholderia invasion by >95% ( Fig 
| Complement-activated vitronectin facilitates bacterial invasion
Vitronectin is an extracellular matrix protein also found in plasma, and has been reported to facilitate the adhesion and invasion of nonphagocytic cells by various pathogenic bacteria. In order to study potential vitronectin recruitment by Burkholderia, immunoblotting with a polyclonal antibody against total vitronectin and a monoclonal antibody specific to a cryptic epitope exposed only upon vitronectin activation were employed. Bacteria exposed to human plasma or the C3 or C5 depleted sera showed similar levels of total vitronectin recruitment (Figures 3a, b and S4) . On the other hand, significantly less activated vitronectin was found bound to bacteria exposed to C3 or C5 depleted sera, demonstrating a need for complement activation to bring about a conformational change in vitronectin (Figure 3a,b) .
Similarly, B. thailandensis was able to bind recombinant vitronectin, but low levels of the activated form were detected (Figure 3c) . B.
thailandensis treated with recombinant vitronectin also demonstrated low levels of invasion into HepG2 cells ( Figure 3D ). In vivo, vitronectin is activated by intermediate complexes such as C5b-7 (Hogasen, Mollnes, & Harboe, 1992; Milis, Morris, Sheehan, Charlesworth, & Pussell, 1993) . To reconstitute the activation of vitronectin with complement, we used C5b6 due to the reported stability of this complex. Incubating the bacterium with recombinant vitronectin and purified C5b,6 protein led to a significant increase in the activated form of vitronectin ( Figure 3e ). This also led to a significantly greater ability of B. thailandensis to invade cells ( Figure 3d ; Hogasen et al., 1992; Milis et al., 1993 ). These observations demonstrate that the complement cascade plays a key role in activating vitronectin recruited by the bacterium upon sera or plasma-exposure, which in turn confers an increased invasive phenotype to Burkholderia.
| Integrin receptor inhibition can suppress plasma-mediated invasion
Vitronectin can interact with integrin receptors via its N-terminal domain, which contains an RGD sequence. Pretreating HepG2 cells with an RGD peptide prior to infection significantly reduced plasmamediated invasion by~68%, compared to treatment with an RGES control peptide (Figure 4a) . Treatment of cells with a monoclonal antibody specifically blocking the α v β 3 integrin also significantly reduced plasma-mediated invasion by~64% (Figure 4b) . Therefore, these data show that interaction with integrins-and in particular with α v β 3 -is critical for mediating this invasion phenotype.
We next used the cyclic RGD pentapeptide cilengitide, an α v integrin inhibitor which has previously been tested in humans for the treatment of glioblastoma, to inhibit this interaction. Cilengitide treatment potently reduced invasion of plasma-exposed B. pseudomallei 
| Nonhypermucoviscous Klebsiella also exhibits plasma-dependent invasion of HepG2 cells
Finally, we investigated whether plasma or serum exposure had a similar effect on invasion by another serum-resistant bacterium known to interact with epithelial cells. K. pneumoniae is a Gram-negative nosocomial pathogen that has classically been associated with causing community-acquired pneumonia and urinary tract infections in immunocompromised patients (Podschun & Ullmann, 1998) . In the last 20 years, a new hyper-virulent variant of K. pneumoniae (hvKp) has emerged, and is the causative agent of an invasive liver abscess syndrome in patients without a history of hepatobiliary disease (Siu, Yeh, Lin, Fung, & Chang, 2012 ). An early report demonstrated Klebsiella invasion into lung epithelial cells in a capsule dependent manner (Cortes, Alvarez, Saus, & Alberti, 2002) . Generally, hvKp is considered an extracellular pathogen, with its virulence factors primarily focused on evading phagocytosis and survival in the extracellular milieu (Shon, Bajwa, & Russo, 2013; Siu et al., 2012 ).
An initial screen was carried out to determine the invasive ability of 11 different K. pneumoniae strains, which had all been isolated from patients with liver abscess formation. When grown in LB broth prior to infection, all strains exhibited a weak ability to infect epithelial cells, although it was observed that nonhypermucoviscous strains generally had higher intracellular bacterial counts at 3 hr postinfection 
| DISCUSSION
Enrichment of Gram-negative bacterial isolates that were resistant to the microbicidal action of serum from bacteremic patients had been observed for more than 50 years (Roantree & Rantz, 1960; Simberkoff, Ricupero, & Rahal, 1976; Taylor, 1983) . Clinical isolates of pathogens such as K. pneumoniae and B. pseudomallei capable of causing metastatic complications are also highly serum resistant (Fang et al., 2007; Ismail et al., 1988) . Thus, the ability of bacteria to remain viable in the bloodstream potentially enables dissemination within the host.
In this study, we show that serum resistance also helps Burkholderia and nonhypermucoviscous Klebsiella enhance their invasion into nonphagocytic cells.
Although plasma exposure had a similar potentiating effect on cell invasion for both Burkholderia and Klebsiella, the longer term host-cell response clearly differed. B. pseudomallei and B. thailandensis were able to increase their intracellular counts by a further 10 to 20 fold within 6 hr after infection. This was accompanied by the hallmark cell fusion triggered by Burkholderia at 12 hr, followed by significantly more host cell death at 20 hr post-infection. On the other hand, intracellular
Klebsiella bacterial counts at 20 hr postinfection were similar to that at 2 hr. Therefore, while HepG2 cells were not able to clear intracellular Klebsiella, the bacterium was not able to actively replicate within this intracellular space. On the other hand, B. pseudomallei is an intracellular bacterium, able to exploit the vitronectin-mediated entry pathway for its own replication and pathogenesis. It is also a form of immune evasion.
Increased cell invasion is not dependent on a transcriptional
response by the bacteria to a plasma-component, nor does it require the T3SS3 locus in Burkholderia. The T3SS3 locus of B. pseudomallei is critical for its virulence, enabling the rapid escape of the pathogen from the endocytic vesicle into its cytoplasmic replicative niche (Galyov, Brett, & DeShazer, 2010; Stevens et al., 2002 ). An early report suggested that an effector secreted by this system, BopE, plays a role in the invasion of epithelial cells (Stevens et al., 2003) . However, the 6 hr postinfection time point at which intracellular bacterial counts were enumerated in that study could reflect differences in endocytic escape and cytoplasmic replication, rather than invasion alone. In agreement with this interpretation, recent studies have reported that the T3SS3 locus is not required for early host cell invasion in B.
pseudomallei (Chen et al., 2011; French et al., 2011) .
Instead, we discovered that enhanced invasion was primarily driven by a plasma factor. This required a functional complement cascade but was downstream of C3 mediated opsonisation. Receptor blocking studies with RGD-domain containing peptide and α V β 3 blocking antibody pointed to vitronectin in facilitating this invasion. Vitronectin is an important component of the ECM, and is also abundantly present in human plasma, with a mean reported concentration of around 500 μg/ml (Boyd, Bradwell, & Thompson, 1993) . As a glycoprotein involved in cell adhesion, migration, and regulation of complement activation, vitronectin is capable of interacting with both cell surface bound integrin receptors and components of the complement and coagulation pathways (Singh, Yu-Ching, & Riesbeck, 2011) . As a result, a large number of pathogens have the ability to bind vitronectin via the C-terminal heparin-binding domain so as to acquire vitronectin-dependent serum resistance and to facilitate host cell adhesion and invasion (Hallstrom et al., 2016; Singh, Su, & Riesbeck, 2010) . However, it is not known what forms of vitronectin they are binding.
We observed that both Burkholderia and Klebsiella can readily attract vitronectin onto its surface in a complement-independent Vitronectin exists predominantly as a monomer in circulating plasma, and gets activated upon interacting with its physiological ligands, including the latter stages of the complement pathway and the thrombin-antithrombin complex (Hogasen et al., 1992; Tomasini & Mosher, 1988) . Activation brings about a conformational change, exposing a number of cryptic epitopes and leading to protein multimerization (Singh et al., 2011) . Vitronectin interacts with FIGURE 5 Cilengitide strongly reduces plasma enhanced invasion of nonphagocytic cells. (a) A549 cells were pretreated with 100 μM cilengitide and infected with plasma (pl) exposed B. pseudomallei (Bp), and intracellular bacterial counts were determined. (b) Lactate dehydrogenase release assay was conducted for cilengitide pre-treated A549 infected with pl exposed Bp at a multiplicity of infection (MOI) of 50:1 for 20 h, with a 0.5% dimethyl sulfoxide (DMSO) control. (c) HepG2 cells were pretreated with 100 μM cilengitide and infected with plasma exposed B. thailandenesis (Bt). Bacterial invasion was measured at 3 hr and (d) intracellular replication at 3 and 6 hr. (e) HepG2 cells pretreated with 100 μM cilengitide were infected with pl exposed Bt at an MOI of 50:1 for 12 hr, resulting in MNGC formation. HT pl and pl + 0.5% DMSO were used as negative controls. (F) fusion index was used to quantify the total percentage of nuclei within multi-nucleated giant cells for (e). Each column in the bar chart is the average of eight measurements per experiment. Data from n = 2 or n = 3 experiments are shown in a scatter plot with mean AE SD in (a-d). Tables below graphs in (a-d) denote fold changes relative to LB, with each column representing a set of experiments. Circles represent experiment 1, triangles experiment 2, and squares experiment 3. * denotes P < 0. Nonhypermucoviscous K. pneumoniae exhibit plasma enhanced invasion. (a) HepG2 and A549 cells were infected with 11 K. pneumoniae strains (Kp) at an multiplicity of infection (MOI) of 100:1. Both hypermucoviscous (hv) and nonhypermucoviscous (non-hv) strains were used. For strain phenotype, refer to Supplementary Table 1. (b) Kp hv strain SGH4 and non-hv strain NUH29 were treated with pl and Ht plasma (HTpl) prior to infection of HepG2 at an MOI of 100:1 for 3 hr and (c) 3 and 24 hr. (d) NUH29 was pretreated with C3 and (e) C5 depleted serum, and used to infect HepG2 for an MOI of 100:1. (f) HepG2 cells were incubated with 10 mM RGD peptide with RGES peptide as a control prior to infection with pl treated NUH29. Data from n = 2 or n = 3 experiments are shown in a scatter plot with mean AE SD in (b-f). Tables below graphs in (b-f) denote fold changes relative to LB, with each column representing a set of experiments. Circles represent experiment 1, triangles experiment 2, and squares experiment 3. * denotes P < 0.05 by pathogens for cell entry (Peake, Greenstein, Pussell, & Charlesworth, 1996; Singh et al., 2010) . Of particular note was a study, pseudomallei and B. thailandensis infection, and an MOI of 100:1 for the K. pneumoniae strains.
The tissue culture plate was centrifuged for 5 min at 250 g, and incubated in a 5% CO 2 incubator at 37 C for 1.5 hr for B. thailandensis and K. pneumoniae infection, and 1 hr for B. pseudomallei infection.
Subsequently, infection media were removed, and cells were washed with 1X PBS before the addition of DMEM with 1,000 μg/mL kanamycin to kill off extracellular bacteria. After a second incubation for 1.5 hr for B. thailandensis and K. pneumoniae infection, and 1 hr for B. pseudomallei infection, media were removed, cells washed with 1X PBS and lysed in 0.2% TritonX100. Dilutions of the lysate were plated onto LB agar in triplicates, incubated at 37°C for 24 to 48 hr, and the CFU enumerated.
| Use of inhibitors
To determine the minimal inhibitory concentration of rifampicin, 100 μl of a 5 × 10 5 bacteria/ml suspension were seeded in a 96
well plate, and treated with 2-fold dilutions of rifampicin. After 4 h of exposure at 37°C, the contents of each well were serially diluted and plated out. The minimal concentration of rifampicin which did not cause a drop in the CFU/ml was established as the minimum inhibitory concentration. For inhibition of transcription, B.
pseudomallei were treated with 0, 16, or 32 μg/ml of rifampicin for 20 minutes, before adding 0 or 1 mM cysteine in RPMI media.
After incubating statically at 37°C for 3.5 h, the cells were spun down and the pellet lysed in PureZOL (Biorad). RNA extraction, cDNA synthesis and real-time polymerase chain reaction quantification were carried out as previously described (Wong, Chen, & Gan, 2015) . To inhibit transcription during plasma exposure, cells were treated with 32 μg/ml rifampicin for 20 min in LB before spinning down and resuspending the pellet in 1 ml of 50% plasma +32 μg/ ml rifampicin for 1 hr.
Antibodies for the vitronectin-specific integrin α v β 3 receptor (MAB1976), and mouse IgG1 isotype control were purchased from times at standardized locations. Within each field of view, the total number of nuclei (a) and the number of nuclei that were observed to be within an MNGC structure (b) were enumerated. The fusion index was expressed as the average percentage of total nuclei that were observed to be within an MNGC structure (=100xb/a).
| Confocal microscopy
HepG2 cells were seeded on cover slips within 24 well tissue culture plates at a density of 120,000 cells per well overnight. They were infected with B. thailandensis at an MOI of 100:1 as described above.
After 90 min of infection, the cells were washed four times and fixed in 4% paraformaldehyde dissolved in PBS for 30 min. After washing three times in PBS + 10 mM glycine, the samples were stained with B. pseudomallei LPS-specific rabbit polyclonal antibodies (provided by Ganjana Lertmemongkolchai, Khon Kaen University, Thailand) for 45 min in saponin permeabilization buffer at a dilution of 100 times.
After three washes, the samples were stained with Pacific blue conjugated secondary antibody also in the presence of saponin permeabilization (200× dilution, ThermoFisher Scientific), and Alexa
Fluor 488 phalloidin (100× dilution, ThermoFisher Scientific) for 45 min. After three rounds of washing in PBS + 10 mM glycine, the cover slips were washed once in water, blotted dry and mounted on glass slides using Prolong Gold antifade reagent (Invitrogen). Laser scanning confocal microscopy was performed with an FV1200
Olympus laser scanning microscope using a 60× oil objective (Olympus LifeSciences). Images were acquired using the Olympus Fluoview viewer (Olympus LifeSciences).
| Statistical analysis
Statistical analysis was carried out using GraphPad Prism software, Version 5. Data were reported as means AE standard deviations. Statistical significance was determined via unpaired t-test. Differences were considered significant at P < 0.05.
